HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 386 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,275,536 | +152658.8% | 33,391 | +49.1% | 0.00% | 0.0% |
| Q1 2023 | $835 | -99.8% | 22,400 | +202.7% | 0.00% | 0.0% |
| Q2 2022 | $335,000 | +20.5% | 7,400 | +7.2% | 0.00% | – |
| Q1 2022 | $278,000 | -60.8% | 6,900 | -60.8% | 0.00% | – |
| Q4 2021 | $710,000 | 0.0% | 17,600 | -1.7% | 0.00% | -100.0% |
| Q3 2021 | $710,000 | +22.2% | 17,900 | +40.9% | 0.00% | – |
| Q2 2021 | $581,000 | +183.4% | 12,700 | +154.1% | 0.00% | – |
| Q1 2021 | $205,000 | -50.8% | 4,999 | -49.0% | 0.00% | -100.0% |
| Q4 2020 | $417,000 | -42.6% | 9,800 | -64.2% | 0.00% | -50.0% |
| Q3 2020 | $726,000 | -24.1% | 27,400 | -26.1% | 0.00% | -33.3% |
| Q2 2020 | $957,000 | +63.6% | 37,056 | +15.1% | 0.00% | +50.0% |
| Q1 2020 | $585,000 | -36.1% | 32,200 | -37.2% | 0.00% | -33.3% |
| Q4 2019 | $915,000 | +42.3% | 51,300 | +21.3% | 0.00% | +200.0% |
| Q3 2019 | $643,000 | +9.9% | 42,300 | +24.1% | 0.00% | 0.0% |
| Q2 2019 | $585,000 | -16.2% | 34,093 | -21.3% | 0.00% | -66.7% |
| Q1 2019 | $698,000 | -49.2% | 43,334 | -54.9% | 0.00% | -25.0% |
| Q4 2018 | $1,373,000 | -15.5% | 96,089 | +7.4% | 0.00% | +33.3% |
| Q3 2018 | $1,625,000 | -52.8% | 89,455 | -49.1% | 0.00% | -62.5% |
| Q2 2018 | $3,444,000 | 0.0% | 175,803 | 0.0% | 0.01% | 0.0% |
| Q1 2018 | $3,444,000 | -35.7% | 175,803 | -33.5% | 0.01% | -60.0% |
| Q4 2017 | $5,359,000 | +71.9% | 264,541 | +47.4% | 0.02% | +66.7% |
| Q3 2017 | $3,118,000 | +25.8% | 179,508 | -6.0% | 0.01% | +9.1% |
| Q2 2017 | $2,479,000 | -15.5% | 191,011 | -15.2% | 0.01% | -31.2% |
| Q1 2017 | $2,934,000 | +124.7% | 225,122 | +45.2% | 0.02% | +100.0% |
| Q2 2016 | $1,306,000 | – | 155,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,829,337 | $266,308,000 | 10.60% |
| BB BIOTECH AG | 6,929,832 | $93,068,000 | 2.95% |
| SECTORAL ASSET MANAGEMENT INC | 2,671,051 | $35,872,000 | 1.64% |
| Sterling Global Strategies LLC | 22,000 | $295,000 | 1.63% |
| Lombard Odier Asset Management (USA) Corp | 1,061,547 | $14,257,000 | 1.24% |
| PYRRHO CAPITAL MANAGEMENT, LP | 90,000 | $1,209,000 | 1.04% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 8,184,003 | $109,911,000 | 0.93% |
| Bellevue Asset Management AG | 246,000 | $3,304,000 | 0.54% |
| Convergence Investment Partners, LLC | 251,748 | $3,381,000 | 0.39% |
| Rhenman & Partners Asset Management AB | 172,000 | $2,310,000 | 0.37% |